Spectral AI (NASDAQ:MDAI) Earns Sell (E+) Rating from Weiss Ratings

Spectral AI (NASDAQ:MDAI)‘s stock had its “sell (e+)” rating reaffirmed by equities researchers at Weiss Ratings in a note issued to investors on Friday,Weiss Ratings reports.

Separately, Wall Street Zen lowered Spectral AI from a “hold” rating to a “strong sell” rating in a research report on Saturday, August 16th. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $3.50.

Spectral AI Price Performance

Shares of NASDAQ MDAI opened at $2.13 on Friday. The stock has a market capitalization of $56.93 million, a P/E ratio of -3.09 and a beta of 0.92. Spectral AI has a 1-year low of $1.01 and a 1-year high of $3.25. The business has a fifty day moving average price of $2.18 and a 200 day moving average price of $2.05.

Spectral AI (NASDAQ:MDAI) last issued its quarterly earnings data on Tuesday, August 12th. The company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.03). The company had revenue of $5.07 million during the quarter, compared to analysts’ expectations of $5.44 million. Spectral AI has set its FY 2025 guidance at EPS. As a group, equities research analysts anticipate that Spectral AI will post -0.48 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Philip James Wealth Mangement LLC acquired a new position in shares of Spectral AI in the third quarter valued at about $27,000. Jane Street Group LLC purchased a new position in shares of Spectral AI in the second quarter worth about $74,000. Marshall Wace LLP purchased a new position in shares of Spectral AI in the second quarter worth about $104,000. DNB Asset Management AS purchased a new position in shares of Spectral AI in the second quarter worth about $107,000. Finally, XTX Topco Ltd purchased a new position in shares of Spectral AI in the second quarter worth about $123,000. 67.08% of the stock is owned by institutional investors and hedge funds.

About Spectral AI

Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.